Placental insulin and insulin-like growth factor I receptors in normal and preeclamptic pregnancies.

Clin Biochem

Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Tlalpan, C.P. 14000 México D.F., México.

Published: March 2005

Objectives: To assess the ligand binding characteristics of insulin and insulin-like growth factor I receptors in normal and preeclamptic placentas.

Design And Methods: This study was done cross sectionally in trophoblast membranes obtained from 10 normotensive and 9 preeclamptic pregnant women. The affinity and number of binding sites of insulin and insulin-like growth factor I receptors were assessed by binding assays and Scatchard plot analysis.

Results: Placental and newborn birth weights were significantly (P < 0.001) lower in the preeclamptic group. The K(d) values of placental insulin receptors (IR) were significantly higher in the preeclamptic group than in the normotensive group (1.08 +/- 0.24 x 10(-9) vs. 0.81 +/- 0.13 x 10(-9) M, P < 0.01), without differences in the number of receptors. In contrast, no differences were observed in the affinity and the number of insulin-like growth factor I receptors (IGF-1R) between groups. Placental weight was associated negatively with the K(d) values of IR (P < 0.05) and positively with the number of placental IGF-1R (P < 0.05); while newborn birth weight was associated positively with the number of IGF-1R (P < 0.05). In addition, both systolic and diastolic blood pressure correlated significantly with K(d) values of placental IR (P < 0.01).

Conclusions: These data demonstrate that preeclampsia is associated with low placental IR affinity. In addition, this study suggests an association between the affinity of IR and number of IGF-1R with placental and/or fetal growth. Furthermore, high blood pressure may affect the affinity of placental IR, but not the affinity or number of placental IGF-1 receptors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2004.10.013DOI Listing

Publication Analysis

Top Keywords

insulin-like growth
16
growth factor
16
factor receptors
16
affinity number
16
insulin insulin-like
12
placental
10
placental insulin
8
receptors normal
8
normal preeclamptic
8
newborn birth
8

Similar Publications

This study investigates the prognostic value of serum biomarkers PD-L1 and IGFBP-2 in patients with esophageal carcinoma. It finds a significant positive correlation between these biomarkers and established tumor markers CEA and CYFRA21-1. The 3-year survival rate for the patient cohort was 45.

View Article and Find Full Text PDF

Recombinant human growth hormone (rhGH) injections combined with Anastrozole are increasingly used to treat adolescent idiopathic short stature (ISS), warranting further research. This study evaluated their effects on height, growth rate and adverse reactions in 72 adolescents with ISS treated at our hospital from December 2021 to December 2022. Patients were divided into a control group (rhGH alone) and a study group (rhGH + Anastrozole).

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the role of miR-483-5p in regulating the overexpression of IGF2 and H19, which are linked to hepatocellular carcinoma (HCC).
  • miR-483-5p enhances IGF2 and H19 expression by binding to their enhancer, activating transcription, and promoting new interactions between the enhancer and gene promoters through chromatin loops.
  • The research highlights that MED1 is crucial in this process, influencing both chromatin structure and the aggressive behavior of HCC cells, indicating potential targets for therapeutic interventions.
View Article and Find Full Text PDF

Purpose: Sarcopenia is an age-related disease that is related to nutritional intake and chronic low-grade inflammation. The aim of this study was to investigate the association of dietary intake, inflammatory markers and sarcopenia among the community-dwelling older adults.

Methods: A total of 1001 older adults aged 60 and above were recruited.

View Article and Find Full Text PDF

Background: A decline in skeletal muscle mass and function known as skeletal muscle sarcopenia is an inevitable consequence of aging. Sarcopenia is a major cause of decreased muscle strength, physical frailty and increased muscle fatigability, contributing significantly to an increased risk of physical disability and functional dependence among the elderly. There remains a significant need for a novel therapy that can improve sarcopenia and related problems in aging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!